These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 34200737

  • 1. Myositis-Related Interstitial Lung Disease: A Respiratory Physician's Point of View.
    Waseda Y.
    Medicina (Kaunas); 2021 Jun 10; 57(6):. PubMed ID: 34200737
    [Abstract] [Full Text] [Related]

  • 2. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T.
    Medicina (Kaunas); 2021 Apr 03; 57(4):. PubMed ID: 33916864
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec 03; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 4. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
    Teel A, Lu J, Park J, Singh N, Basharat P.
    Semin Arthritis Rheum; 2022 Dec 03; 57():152088. PubMed ID: 36116345
    [Abstract] [Full Text] [Related]

  • 5. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F, Wang J, Zhang P, Zuo Y, Ye L, Wang G, Shu X.
    Front Immunol; 2022 Dec 03; 13():879266. PubMed ID: 35603153
    [Abstract] [Full Text] [Related]

  • 6. Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies.
    Chen F, Li S, Wang T, Shi J, Wang G.
    Am J Med Sci; 2018 Jan 03; 355(1):48-53. PubMed ID: 29289262
    [Abstract] [Full Text] [Related]

  • 7. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun 03; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 8. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T, Cavazzana I, Ceruti P, Fredi M, Modina D, Berlendis M, Franceschini F.
    Clin Rev Allergy Immunol; 2021 Feb 03; 60(1):87-94. PubMed ID: 33141387
    [Abstract] [Full Text] [Related]

  • 9. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases.
    Mehta AA, Paul T, Cb M, Haridas N.
    BMJ Case Rep; 2021 Apr 28; 14(4):. PubMed ID: 33910791
    [Abstract] [Full Text] [Related]

  • 10. [Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].
    Gono T, Katsumata Y, Kawaguchi Y.
    Brain Nerve; 2013 Nov 28; 65(11):1275-82. PubMed ID: 24200605
    [Abstract] [Full Text] [Related]

  • 11. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Weng CT, Huang TH, Wu CH, Sun YT.
    Arthritis Res Ther; 2024 Aug 22; 26(1):152. PubMed ID: 39175076
    [Abstract] [Full Text] [Related]

  • 12. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 13. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, Wang G, Ge Y.
    Front Immunol; 2022 Feb 12; 13():987841. PubMed ID: 36110863
    [Abstract] [Full Text] [Related]

  • 14. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan 12; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T.
    Autoimmunity; 2006 May 12; 39(3):233-41. PubMed ID: 16769657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.